Supernus Pharmaceuticals Assets & Liabilities Overview 2011-2023 | SUPN
Supernus Pharmaceuticals assets & liabilities overview from 2011 to 2023. Assets & liabilities overview can be defined as overview of the balance sheet showing the primary categories of assets, liabilities and equity in a single chart.
Supernus Pharmaceuticals Annual Assets & Liabilities Overview
(Millions of US $) |
Supernus Pharmaceuticals Quarterly Assets & Liabilities Overview
(Millions of US $) |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.580B |
$0.608B |
|
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system diseases. It is developing several product candidates in neurology and psychiatry to address opportunities in epilepsy and attention deficit hyperactivity disorder. Supernus Pharmaceuticals Inc. is based in Rockville, Maryland.
|
